Applications of Spherical Nucleic Acids

Jan 31, 2017 by in ONCOLOGY Comments Off on Applications of Spherical Nucleic Acids

Fig. 1 Different mechanisms of intracellular action of antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). a Mechanism of action for ASOs, which bind complementary mRNA and cause inhibition of translation…

read more

Nanoparticles for Cancer Imaging and Therapy

Jan 31, 2017 by in ONCOLOGY Comments Off on Nanoparticles for Cancer Imaging and Therapy

Fig. 1 a Surfactant-free synthesis of NMOFs [27]. b, c Representative SEM images of NMOFs synthesized by nanoprecipitation (b) [48] and solvothermal method (c) [31]. Reprinted with permission from [27]. Copyright…

read more

Chemotherapy and Imaging

Jan 31, 2017 by in ONCOLOGY Comments Off on Chemotherapy and Imaging

Fig. 1 a–d Nanodiamond surfaces possess versatile chemical–physical properties that can mediate potent drug binding and marked improvements in MRI contrast efficiency levels. Reprinted with permission from Nature Publishing Group Furthermore,…

read more

Nanotherapeutics in Clinical Trials

Jan 31, 2017 by in ONCOLOGY Comments Off on Nanotherapeutics in Clinical Trials

Phase Year initiated Description Cancer indication ClinicalTrials.gov identifier 0 2014 Silica imaging nanoparticle Head and neck, melanoma, prostate, cervical, uterine NCT02106598 0 2014 Magnetic nanoparticle thermoablation Prostate NCT02033447 0 2013…

read more

and Nanoparticles

Jan 31, 2017 by in ONCOLOGY Comments Off on and Nanoparticles

Fig. 1 Schematic drawing of radiocatalysis by nanoparticles. Exposure of nanoparticles to ionizing radiation (e.g. X-rays) causes Compton and Photoelectric effects—photoelectrons and Auger electrons (e−) are ejected from the nanoparticles as…

read more

Cancer Nanotherapeutics

Jan 31, 2017 by in ONCOLOGY Comments Off on Cancer Nanotherapeutics

Fig. 1 Illustration of the EPR effect depicting the discontinuous epithelium lining blood vessel walls of a tumor with concurrent poor lymphatic drainage compared to normal tissue. Nanoparticles can passively accumulate…

read more

Lipid Nanoparticles for Cancer Medicine

Jan 31, 2017 by in ONCOLOGY Comments Off on Lipid Nanoparticles for Cancer Medicine

Modality Signal Contrast agent Sensitivity [1] (mol label) Resolution [1] Tissue penetration Risk Primarily morphological/anatomical imaging modalities MRI Magnetic fields Gadolinium, iron oxide nanoparticles 10−9–10−6 50 µm Unlimited Harmless CT X-rays…

read more

Nanoparticles Interact with Cancer Cells

Jan 31, 2017 by in ONCOLOGY Comments Off on Nanoparticles Interact with Cancer Cells

Fig. 1 Schematic of some of the mechanisms of endocytosis that have so far been elucidated. The focus in this chapter will be on clathrin-mediated, caveolar-type, macropinocytosis, and phagocytosis mechanisms. Adapted…

read more

High-Density Lipoprotein-Like Nanoparticles as Cancer Therapy

Jan 31, 2017 by in ONCOLOGY Comments Off on High-Density Lipoprotein-Like Nanoparticles as Cancer Therapy

Structural feature Examples Composition of particle core Cholesteryl esters [54] Inorganic scaffolds (Au) [89] Shape Discoidal [80] Spherical [89] Protein associated with particle Full-length apoA-I [97] ApoA-I-mimetic peptide [99] ApoE…

read more
Get Clinical Tree app for offline access